Literature DB >> 24995466

Prenatal exposure to the brominated flame retardant hexabromocyclododecane (HBCD) impairs measures of sustained attention and increases age-related morbidity in the Long-Evans rat.

Patrick Miller-Rhodes1, Maria Popescu2, Calla Goeke1, Toni Tirabassi2, Lauren Johnson1, Vincent P Markowski1.   

Abstract

Hexabromocyclododecane (HBCD) is a brominated flame retardant that is widely-used in foam building materials and to a lesser extent, furniture and electronic equipment. After decades of use, HBCD and its metabolites have become globally-distributed environmental contaminants that can be measured in the atmosphere, water bodies, wildlife, food staples and human breastmilk. Emerging evidence suggests that HBCD can affect early brain development and produce behavioral consequences for exposed organisms. The current study examined some of the developmental and lifelong neurobehavioral effects of prenatal HBCD exposure in a rat model. Pregnant rats were gavaged with 0, 3, 10, or 30mg/kg HBCD from gestation day 1 to parturition. A functional observation battery was used to assess sensorimotor behaviors in neonates. Locomotor and operant responding under random ratio and Go/no-go schedules of food reinforcement were examined in cohorts of young adult and aged rats. HBCD exposure was associated with increased reactivity to a tailpinch in neonates, decreased forelimb grip strength in juveniles, and impaired sustained attention indicated by Go/no-go responding in aged rats. In addition, HBCD exposure was associated with a significant increase in morbidity in the aged cohort. One health complication, a progressive loss of hindleg function, was observed only in the aged, 3mg/kg HBCD animals. These effects suggest that HBCD is a developmental neurotoxicant that can produce long-term behavioral impairments that emerge at different points in the lifespan following prenatal exposure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attention, behavior; Development; Flame retardant; Hexabromocyclododecane; Prenatal exposure

Mesh:

Substances:

Year:  2014        PMID: 24995466     DOI: 10.1016/j.ntt.2014.06.009

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  6 in total

1.  Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCDD.

Authors:  Kelly R Genskow; Joshua M Bradner; Muhammad M Hossain; Jason R Richardson; W Michael Caudle
Journal:  Neurotoxicol Teratol       Date:  2015-06-12       Impact factor: 3.763

2.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

3.  A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice.

Authors:  Claude Emond; Michael J DeVito; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2021-08-11       Impact factor: 4.460

4.  Motor deficits, impaired response inhibition, and blunted response to methylphenidate following neonatal exposure to decabromodiphenyl ether.

Authors:  Vincent P Markowski; Patrick Miller-Rhodes; Randy Cheung; Calla Goeke; Vincent Pecoraro; Gideon Cohen; Deena J Small
Journal:  Neurotoxicol Teratol       Date:  2017-07-29       Impact factor: 3.763

5.  Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture.

Authors:  David T Szabo; Wimal Pathmasiri; Susan Sumner; Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2016-11-04       Impact factor: 9.031

6.  Head-to-Head Study of Developmental Neurotoxicity and Resultant Phenotype in Rats: α-Hexabromocyclododecane versus Valproic Acid, a Recognized Model of Reference for Autism Spectrum Disorders.

Authors:  Chloé Morel; Armelle Christophe; Katy Maguin-Gaté; Justine Paoli; Jonathan David Turner; Henri Schroeder; Nathalie Grova
Journal:  Toxics       Date:  2022-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.